<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16492">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01722409</url>
  </required_header>
  <id_info>
    <org_study_id>20121009</org_study_id>
    <nct_id>NCT01722409</nct_id>
  </id_info>
  <brief_title>A Better Choice for Patients Undergoing Endovascular Coil Embolization</brief_title>
  <official_title>Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators designed a double-blind, randomized placebo-controlled study to determine
      the effects of dexmedetomidine on the recovery characteristics of patients who were
      scheduled to undergo endovascular coil embolization.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    No patients enrolled until now
  </why_stopped>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Observing the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.</measure>
    <time_frame>At the end of the operation and 24 hours later</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The time from termination of the general anesthetic to the time that the patient's eyes opened.  Anesthesiologists collected information on emergence agitation, postoperative nausea and vomiting for 24 hours after the surgery.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>sevoflurane and saline infusion</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>After induction of general anesthesia, Group S received a placebo infusion of normal saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane and 0.5 μg/kg dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane and 1 μg/kg dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane and 0.5 μg/kg dexmedetomidine</intervention_name>
    <description>After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.</description>
    <arm_group_label>sevoflurane and 0.5 μg/kg dexmedetomidine</arm_group_label>
    <other_name>DEX1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane and 1 μg/kg dexmedetomidine</intervention_name>
    <description>After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.</description>
    <arm_group_label>sevoflurane and 1 μg/kg dexmedetomidine</arm_group_label>
    <other_name>DEX2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:18-65 years old ASA I or ASA II patients undergoing ECE treatment for
        intracranial aneurysms were included.

        Exclusion Criteria:Patients were excluded based on the following parameters: older than 65
        yrs, a history of mental illness, recent use of sedatives or analgesics and with
        sensation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Ma, M.D.,PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology, the First Hospital of CMU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wen-fei Tan</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>March 17, 2014</lastchanged_date>
  <firstreceived_date>November 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine, endovascular coil embolization</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
